RCSI joins Limerick’s Serosep to tackle ulcerative colitisLeigh Mc Gowranon January 23, 2024 at 15:46 Silicon RepublicSilicon Republic
RCSI and Serosep aim to find biomarkers that can predict the progression of the inflammatory bowel disease, to improve treatment options for patients.
Read more: RCSI joins Limerick’s Serosep to tackle ulcerative colitis